Burning Rock Biotech (BNR) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.
- Burning Rock Biotech's Income from Continuing Operations rose 5443.72% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year increase of 7454.97%. This contributed to the annual value of -$45.9 million for FY2024, which is 4980.47% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Income from Continuing Operations is -$2.3 million, which was up 5443.72% from -$1.3 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Income from Continuing Operations high stood at -$1.3 million for Q2 2025, and its period low was -$41.2 million during Q1 2022.
- Over the past 5 years, Burning Rock Biotech's median Income from Continuing Operations value was -$23.9 million (recorded in 2023), while the average stood at -$21.6 million.
- As far as peak fluctuations go, Burning Rock Biotech's Income from Continuing Operations plummeted by 20865.07% in 2021, and later surged by 9131.9% in 2025.
- Burning Rock Biotech's Income from Continuing Operations (Quarter) stood at -$39.8 million in 2021, then rose by 22.56% to -$30.8 million in 2022, then rose by 26.79% to -$22.5 million in 2023, then soared by 57.06% to -$9.7 million in 2024, then soared by 76.29% to -$2.3 million in 2025.
- Its Income from Continuing Operations stands at -$2.3 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.8 million for Q1 2025.